Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Pharvaris N.V. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +15 vs. Q1 2026
- Shares held
- 64.5M
- +5.44M (+9.2%) vs. Q1 2026
- Total value
- $2.23B
- +$562.2M (+33.7%) vs. Q1 2026
- New holders
- 24
- 49 more added
- Sold out
- 9
- 33 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kynam Capital Management, LP | 661,795 | $22.9M | 1.26% | +21,400+3.3% | Added |
| Foresite Capital Management V, LLC | 664,142 | $23.0M | 6.34% | +470,017+242.1% | Added |
| Patient Square Capital LP | 671,209 | $23.2M | 3.60% | +178,209+36.1% | Added |
| Jones Hill Capital LP | 677,879 | $23.4M | 4.98% | +510,865+305.9% | Added |
| Soleus Capital Management, L.P. | 730,907 | $25.3M | 0.87% | +28,855+4.1% | Added |
| Cormorant Asset Management, LP | 750,000 | $25.9M | 1.33% | −250,000−25.0% | Reduced |
| BlackRock, Inc. | 771,454 | $26.7M | 0.00% | +14,241+1.9% | Added |
| Seven Fleet Capital Management LP | 774,501 | $26.8M | 4.42% | +457,804+144.6% | Added |
| 5AM Venture Management, LLC | 797,600 | $27.6M | 9.58% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 881,299 | $30.5M | 1.63% | +62,971+7.7% | Added |
| TCG Crossover Management, LLC | 1,008,229 | $34.9M | 0.84% | +1,008,229 | New |
| Saturn V Capital Management LLC | 1,314,122 | $45.4M | 6.52% | +112,720+9.4% | Added |
| Novo Holdings A/S | 1,400,000 | $48.4M | 2.82% | −350,000−20.0% | Reduced |
| Commodore Capital LP | 1,425,000 | $49.3M | 2.93% | −493,970−25.7% | Reduced |
| Point72 Asset Management, L.P. | 1,641,200 | $56.8M | 0.09% | +634,184+63.0% | Added |
| Polar Capital Holdings Plc | 2,326,389 | $80.4M | 0.23% | +1,545,373+197.9% | Added |
| Wellington Management Group LLP | 2,392,934 | $82.7M | 0.01% | +274,034+12.9% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,675,509 | $92.5M | 5.50% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 3,376,042 | $116.7M | 1.22% | +250,000+8.0% | Added |
| EQT Fund Management S.a r.l. | 3,424,609 | $118.4M | 13.73% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,653,310 | $126.3M | 0.36% | 00.0% | Unchanged |
| venBio Partners LLC | 4,643,430 | $160.6M | 30.92% | +4,126+0.1% | Added |
| Foresite Capital Management IV, LLC | 4,778,581 | $165.2M | 56.95% | 00.0% | Unchanged |
| General Atlantic LLC | 6,550,757 | $226.5M | 7.79% | −1,480,495−18.4% | Reduced |
| FMR LLC | 6,565,272 | $227.0M | 0.01% | +280,800+4.5% | Added |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −158,019−100.0% | Sold out |
| DV Trading LLC | 0 | $0 | 0.00% | −143,966−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −82,800−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −77,646−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −52,148−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,500−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −13,723−100.0% | Sold out |